Carisma Therapeutics, Inc.
CARM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18 | $78 | $24 | $163 |
| Short-Term Investments | $1 | $0 | $28 | $0 |
| Receivables | $3 | $0 | $0 | $24 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $3 | $3 | $18 |
| Total Curr. Assets | $24 | $80 | $55 | $206 |
| Property Plant & Equip (Net) | $6 | $9 | $13 | $0 |
| Goodwill | $0 | $0 | $0 | $13 |
| Intangibles | $0 | $0 | $0 | $15 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $72 |
| Other NC Assets | $0 | $0 | $4 | $7 |
| Total NC Assets | $7 | $9 | $18 | $107 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $30 | $90 | $72 | $313 |
| Liabilities | – | – | – | – |
| Payables | $2 | $4 | $2 | $3 |
| Short-Term Debt | $2 | $2 | $5 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $1 | $2 | $0 |
| Other Curr. Liab. | $12 | $9 | $11 | $9 |
| Total Curr. Liab. | $16 | $16 | $20 | $12 |
| LT Debt | $1 | $1 | $36 | $0 |
| Deferred Rev, NC | $0 | $45 | $45 | $2 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $76 |
| Other NC Liab. | $42 | $1 | $115 | $52 |
| Total NC Liab. | $42 | $47 | $195 | $129 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $3 | $6 | $0 |
| Total Liabilities | $58 | $63 | $215 | $141 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$306 | -$245 | -$158 | -$316 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $278 | $272 | $1 | $488 |
| Total Equity | -$28 | $27 | -$157 | $172 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $14 | $0 |
| Total Liab. & Tot. Equity | $30 | $90 | $72 | $313 |
| Net Debt | -$15 | -$74 | $16 | -$163 |